Senior Lecturer at Universiti Sains Malaysia ,Malaysia
Dr. Amer Hayat Khan is a dedicated academic and researcher in the field of Clinical Pharmacy. Serving as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), he brings over a decade of expertise in teaching, clinical practice, and pharmaceutical research. A native of Pakistan, Dr. Khan has established himself as a prominent figure in pharmacyhttps://globaldiseases.org/amer-khan-education-and-adherence-best-scholar-award-1607/ education and research across Asia. He is actively involved in supervising postgraduate research, conducting clinical trials, and contributing to numerous international collaborations. His strong academic background, paired with a commitment to public health and community service, reflects his holistic approach to healthcare advancement. With over 300 publications, a Scopus H-index of 26, and a significant cumulative impact factor, Dr. Khan continues to influence both policy and practice in pharmacy. He maintains a strong presence in global research platforms, further extending his reach and collaborative potential across the scientific community.
🔹 Professional Profile
🏆Strengths for the Award
1. Academic Excellence and Educational Leadership
Dr. Khan holds a Ph.D. in Clinical Pharmacy and has demonstrated exceptional academic performance throughout his career. He has contributed significantly to curriculum development, undergraduate and postgraduate teaching, and the design of experiential learning programs such as clerkships and OSPhE assessments. His pedagogical methods integrate real-world clinical insights, reinforcing evidence-based learning.
2. Pioneering Research on Adherence and Education
Dr. Khan’s research, particularly in medication adherence, infectious diseases, and clinical education models, addresses crucial healthcare challenges. His recent work on TB treatment adherence using the Health Belief Model exemplifies innovative, theory-driven educational interventions with clinical impact.
3. Mentorship and Capacity Building
With supervision of over 50 postgraduate theses, including 29 Ph.D. candidates, Dr. Khan has made major contributions to building future research leaders. His mentorship spans multiple continents, fostering global capacity in pharmacy research.
4. Global Research Collaborations
Dr. Khan’s collaborations with institutions in South Asia, the Middle East, and Australia highlight his international influence. His work aligns with cross-border healthcare priorities such as antimicrobial resistance and geriatric pharmacotherapy, making him a central figure in translational research.
5. Outstanding Publication Record
With 300+ publications, a Scopus h-index of 26, and cumulative impact factor exceeding 426, his output reflects both quality and consistency. His articles are widely cited, spanning high-impact journals and addressing both regional and global public health needs.
6. Community and Public Health Engagement
Dr. Khan’s involvement in awareness campaigns, patient education initiatives, and antibiotic stewardship programs underlines his commitment to public service. His work bridges academic insight with real-world implementation, a rare and valuable quality in modern scholarship.
🎓 Education
Dr. Amer Hayat Khan pursued his higher education with a clear focus on pharmacy. He obtained his Ph.D. in Clinical Pharmacy from Universiti Sains Malaysia (USM), where he later joined the academic faculty. Prior to that, he completed his M.Phil and Bachelor of Pharmacy degrees at Gomal University in Pakistan. His academic training laid a strong foundation in both pharmaceutical sciences and clinical pharmacy practice, equipping him with in-depth knowledge essential for advanced teaching and research. To complement his formal education, Dr. Khan earned certifications in Good Clinical Practices (GCP) from the Ministry of Health, Malaysia. These qualifications have allowed him to operate effectively in both academic and clinical environments, emphasizing evidence-based approaches in pharmacy education and research. His diverse educational background supports his multifaceted roles as a teacher, researcher, and mentor in the field of clinical pharmacy at the international level.
💼 Experience
Dr. Amer Hayat Khan has over a decade of academic and clinical experience in pharmacy. Since October 2011, he has served as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM). His responsibilities include teaching undergraduate and postgraduate pharmacy courses, supervising thesis research, and conducting structured hospital visits for pharmacy clerkship. Dr. Khan also plays a pivotal role in training students through Objective Structured Pharmacy Examinations (OSPhE), problem-solving sessions, and community health initiatives. As a Clinical Pharmacy Specialist, he integrates research with teaching and service delivery, enhancing pharmaceutical care training. He has also supervised over 50 postgraduate research projects, contributing extensively to capacity-building in pharmacy education. His experience spans across national borders, involving active collaborations with research institutions in the Middle East, South Asia, and Australia. His career reflects a commitment to advancing pharmacy practice through education, innovation, and international research partnerships.
🏆Awards and Honors
Dr. Amer Hayat Khan has been the recipient of numerous awards and competitive research grants throughout his academic career. These accolades recognize his outstanding contributions to clinical pharmacy education, research, and service. He is actively engaged in academic peer-review processes, serving as a reviewer for prestigious journals and as an examiner for postgraduate theses at various universities. His extensive research portfolio, supported by international and institutional grants, has earned him recognition within and beyond Malaysia. He has played a key role in advancing pharmaceutical sciences, particularly through impactful studies on infectious diseases, antibiotic stewardship, and adherence issues. With a cumulative article impact factor of over 426.50 and an abstract impact factor exceeding 144.44, his scientific output has made a significant contribution to global pharmacy research. His achievements are not only academic but also reflect his dedication to public health and community engagement, solidifying his position as a leader in the field.
Dr. Amer Hayat Khan’s research interests center around Clinical Pharmacy with a strong focus on Infectious Diseases, Antibiotic Stewardship, Geriatric Issues, Adherence Challenges, and Epidemiology. His work aims to bridge the gap between clinical practice and academic research by addressing real-world pharmaceutical challenges. He has supervised 29 Ph.D. and numerous master’s research projects, often involving clinical trials, observational studies, and pharmacological interventions. His research frequently explores medication adherence in elderly populations and the optimization of antibiotic use to combat resistance. Through international collaborations with institutions across Saudi Arabia, India, Pakistan, UAE, and Australia, he has contributed to a global understanding of pharmacy practices. Dr. Khan’s publications are widely cited, and his projects often emphasize evidence-based practices that can inform healthcare policy and improve clinical outcomes. His research agenda reflects a commitment to improving patient care and enhancing pharmaceutical education through innovative, interdisciplinary approaches.
📚 Publications Top Notes
Pharmacist-led Education Intervention to Improve Pulmonary Tuberculosis Treatment Adherence Through the Health Belief Model in Malaysia: A Study Protocol for a Randomized Trial
Authors: R Ahmad, SMS Ghadzi, IABH Ali, SAS Sulaiman, AH Khan
Journal: Monaldi Archives for Chest Disease, 2025
Summary: This study outlines a randomized controlled trial (RCT) protocol investigating the effectiveness of a pharmacist-led intervention based on the Health Belief Model (HBM) to improve treatment adherence among pulmonary TB patients in Malaysia. The intervention aims to address patient beliefs, perceived severity, susceptibility, and barriers to adherence, using structured educational sessions.
Risk Factors of Acute Kidney Injury Patients Presenting to Tertiary Care Hospital
Authors: A Khan, W Khan, A Jabbar, M Khan, Z Ullah
Journal: Pakistan Journal of Intensive Care Medicine, Vol. 5(01), Page 92, 2025
Summary: This cross-sectional study identifies clinical and demographic risk factors associated with Acute Kidney Injury (AKI) among patients in a tertiary care setting in Pakistan. Major findings point to the role of comorbidities such as diabetes, hypertension, and sepsis as leading contributors.
Evaluation of Social and Clinical Factors Associated with Adverse Drug Reactions Among Children with Drug-Resistant Tuberculosis in Pakistan
Authors: MS Said, R Fatima, R Ahmad, MBA Al Rawi, F Jan, S Faisal, I Khan, AH Khan, et al.
Journal: Tropical Medicine and Infectious Disease, 10(7), Article 176, 2025
Summary: This research examines the correlation between social determinants (like caregiver education) and clinical features (polypharmacy, nutritional status) in the incidence of adverse drug reactions in pediatric DR-TB patients. It advocates for improved monitoring and targeted risk assessments.
Impact of COVID-19 on Clinical Characteristics in Type 2 Diabetes Patients: A Prospective, Longitudinal, Observational Study
Authors: T Azim, AH Khan, F Sadiq, SAS Sulaiman, DAM Noor, U Wahab, O Ishtiaq
Journal: Diabetes Research and Clinical Practice, Article 112316, 2025
Summary: This study explores how COVID-19 altered clinical outcomes and glycemic control in T2DM patients over time. Results reveal significant metabolic derangements, increased insulin requirements, and higher hospitalization rates during infection periods.
Systematic Review and Meta-analysis Protocol of Impact of Pharmacist-Led Antibiotic Stewardship Audit-Feedback Intervention
Authors: DS Jawhar, AH Khan, K Alam
Journal: MethodsX, Article 103399, 2025
Summary: The paper proposes a protocol for a systematic review and meta-analysis aimed at evaluating the effectiveness of pharmacist-led audit-feedback interventions on antibiotic prescribing practices. It adheres to PRISMA-P standards and seeks to inform global antimicrobial stewardship policies.
Prevalence of Cardiovascular Disease Among Tuberculosis Patients in Penang General Hospital, Malaysia
Authors: B Kingrani, AH Khan, SN Harun, FAS Khiery, IAH Ali, A Qureshi
Journal: [Details not specified], 2025
Summary: This epidemiological study assesses the coexistence of cardiovascular disease (CVD) among TB patients, highlighting a high prevalence and stressing the need for integrated CVD screening in TB care programs.
Cardiovascular Mortality Among Tuberculosis Patients
Authors: B Kingrani, AH Khan, SN Harun, A Qureshi, IAH Ali, MB Al-Rawi, I Khan
Journal: [Details not specified], 2025
Summary: The study reports an increased rate of cardiovascular-related deaths in TB patients, suggesting that TB-induced systemic inflammation might accelerate cardiovascular risks. Calls for enhanced cardiovascular monitoring are made.
Exploring Antibiotic Resistance Patterns in Escherichia coli Isolates from Urinary Tract Infections: A Retrospective Study
Authors: R Alkhawaldeh, L Gharaibeh, AH Khan, K Abu Hammour, M Zawiah, et al.
Journal: Journal of Clinical Medicine, 14(9), Article 3196, 2025
Summary: Retrospective data analysis reveals increasing antibiotic resistance in E. coli isolates, especially to fluoroquinolones and beta-lactams. The paper recommends urgent antimicrobial stewardship and rational prescription practices.
Parental Awareness and Practices of Self-Medication with Antibiotics Among Hospitalized Children: Findings and Implications from a Cross-Sectional Study
Authors: ZU Mustafa, AH Khan, M Salman, SN Harun, J Meyer, B Godman
Journal: Advances in Human Biology, 2025
Summary: This cross-sectional study identifies significant gaps in parental understanding of antibiotic use in pediatric patients. The study emphasizes the role of public health education in combating antibiotic misuse.
Baseline Predictors of Antibiotics De-escalation from Empirical Therapies in an Intensive Care Unit: A Five-Year Retrospective Study
Authors: AL Arulappen, AH Khan, M Danial, SS Hasan, TS Chow, NJ Ahmed, et al.
Journal: BMC Infectious Diseases, 25(1), Article 369, 2025
Summary: Over a 5-year period, the study identifies clinical predictors (e.g., culture sensitivity results, clinical stability) that influenced successful antibiotic de-escalation in ICU patients. The study supports promoting de-escalation to reduce resistance.
📌 Conclusion
Dr. Amer Hayat Khan exemplifies a balanced academic professional with strengths in teaching, research, and clinical practice. His extensive educational background, coupled with over a decade of academic service at Universiti Sains Malaysia, underlines his dedication to advancing the field of Clinical Pharmacy. As a mentor, he has significantly contributed to postgraduate education and research supervision, while his global research collaborations highlight his international impact. Dr. Khan’s work in infectious diseases, antibiotic stewardship, and elderly care aligns with current healthcare priorities, reflecting his forward-thinking approach. His recognition through awards, grants, and high-impact publications attests to the quality and relevance of his contributions. Committed to community health and evidence-based practice, he continues to influence the next generation of pharmacists and healthcare professionals. His career trajectory positions him not only as an academic leader but also as a valuable contributor to global public health and clinical pharmacy advancement.